Mega Biotech Deal: Pfizer Acquiring Medivation For $14 Billion Pfizer Inc. has agreed to take over biopharmaceutical company Medivation Inc. for a whopping $14 billion. The deal gives an impetus to Pfizer’s oncology-oriented ambitions. by Anu Passary